Tag: announces

Antibe Therapeutics Inc. Announces Proposed Offering of Units
Financial

Antibe Therapeutics Inc. Announces Proposed Offering of Units

TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Company“) (TSXV: ATE) (OTCQX: ATBPF) a diversified biotechnology company announced today that it has filed a preliminary short form prospectus in connection with a proposed marketed offering of units of the Company (the “Units”) for minimum gross proceeds of $3,000,000 and maximum gross proceeds of $5,000,000 (the […]

Cesca Therapeutics Announces Senior Management Promotions
Biologics

Cesca Therapeutics Announces Senior Management Promotions

RANCHO CORDOVA, Calif., April 03, 2017 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the following senior management promotions, effective immediately. Ms. Haihong Zhu, who most recently served as Director of Sales, has been promoted to the […]

DJO Global Announces Financial Results for Fourth Quarter and Fiscal Year End 2016
Financial

DJO Global Announces Financial Results for Fourth Quarter and Fiscal Year End 2016

March 08, 2017 SAN DIEGO–(BUSINESS WIRE)–DJO Global, Inc. (“DJO” or the “Company”), a leading global provider of medical technologies designed to get and keep people moving, today announced financial results for its public reporting subsidiary, DJO Finance LLC (“DJOFL”), for the fourth quarter and fiscal year ended December 31, 2016. […]

DJO Global Announces Appointment of Bryan McMillan as President, Regeneration
Recon Top Stories

DJO Global Announces Appointment of Bryan McMillan as President, Regeneration

March 1, 2017 SAN DIEGO–(BUSINESS WIRE)– DJO Global, Inc., a leading global provider of medical technologies designed to get and keep people moving, today announced the appointment of Bryan McMillan as President Regeneration, effective March 1, 2017. As President of DJO’s Regeneration business, Mr. McMillan will be responsible for both commercial growth […]

Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
Financial

Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.

PLAINSBORO, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (“Integra”) (NASDAQ:IART), a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary, Integra Derma, Inc. (“Offeror”), to purchase all outstanding common and preferred shares of Derma Sciences, Inc. (“Derma Sciences”) (NASDAQ:DSCI) at […]

Bioness Announces First European Implants for StimRouter Neuromodulation System
Extremities Neuro

Bioness Announces First European Implants for StimRouter Neuromodulation System

VALENCIA, Calif., Feb. 22, 2017 /PRNewswire/ — Bioness, Inc., the leading provider of cutting edge, clinically supported rehabilitation therapies, today announced the first series of successful StimRouter Neuromodulation System implantations in Europe at Radboud University Medical Center (Nijmegen, Netherlands), South Victoria University (Cork, Ireland), and Kliniek Park Leopold Chirec (Brussels, Belgium). […]

Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO
Biologics

Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO

BELGRADE, Mont., Feb. 22, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Carl O’Connell as the permanent CEO, effective February 17th, 2017. Mr. O’Connell previously served as president of Xtant since […]

GS Medical USA Announces New Product Portfolio and Company Enhancements
Spine

GS Medical USA Announces New Product Portfolio and Company Enhancements

IRVINE, Calif., Feb. 20, 2017 /PRNewswire/ — GS Solutions Inc., DBA GS Medical USA (GSM), a global manufacturer and supplier of spinal implants, instrumentation and developer of high-quality surgical solutions, today announced several influential advancements for the organization. Following a strong close to the 2016 fiscal year, GSM is poised and […]

Nanovis announces a Successful Alpha Launch of the FortiCore® PLIF and the 2,000th FortiCore® Interbody Implantation.
Spine Top Stories

Nanovis announces a Successful Alpha Launch of the FortiCore® PLIF and the 2,000th FortiCore® Interbody Implantation.

Carmel and Columbia City, Ind. (February 16, 2017) – Nanovis, a life sciences company committed to developing implant systems that reduce fixation related complications and infections, today announced the successful alpha launch of its FortiCore® PLIF featuring a deeply porous titanium scaffold interdigitated with a PEEK core, and implantation of […]

Spinal Simplicity Announces Receipt of FDA Clearance for Minuteman® G3-R Removable End Fusion Implant
Regulatory

Spinal Simplicity Announces Receipt of FDA Clearance for Minuteman® G3-R Removable End Fusion Implant

OVERLAND PARK, KANSAS (PRWEB) FEBRUARY 03, 2017 Spinal Simplicity, a medical device company developing innovative solutions to treat complex surgical problems, has received its third 510(k) clearance from FDA for the Minuteman G3-R spinal implant, part of the Minuteman family of supplemental fusion and fixation devices. The Minuteman G3-R may […]

CONMED Corporation Announces Fourth Quarter and Fiscal Year 2016 Financial Results
Financial

CONMED Corporation Announces Fourth Quarter and Fiscal Year 2016 Financial Results

February 01, 2017 UTICA, N.Y.–(BUSINESS WIRE)–CONMED Corporation (Nasdaq:CNMD) today announced financial results for the fourth quarter and fiscal year ended December 31, 2016. Fourth Quarter 2016 Highlights Sales of $204.1 million increased 6.8% as reported compared to the fourth quarter of 2015. On a constant currency basis, sales increased 9.1% but […]